cysteine and Hyperlipoproteinemias

cysteine has been researched along with Hyperlipoproteinemias in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Breuer, ML; Havekes, LM; Hofker, MH; van der Boom, H; van der Zee, A; van Dijk, KW; van Gorp, PJ; van Vlijmen, BJ; van't Hof, HB	1
Coetzee, GA; de Villiers, WJ; Henderson, HE; Marais, AD; van der Westhuyzen, DR	1

Other Studies

2 other study(ies) available for cysteine and Hyperlipoproteinemias

Article	Year
In the absence of endogenous mouse apolipoprotein E, apolipoprotein E2(Arg-158 --> Cys) transgenic mice develop more severe hyperlipoproteinemia than apolipoprotein E3-Leiden transgenic mice. The Journal of biological chemistry, 1996, Nov-29, Volume: 271, Issue:48 Topics: Animals; Apolipoproteins E; Arginine; Cells, Cultured; Cysteine; Genes, Dominant; Heymann Nephritis Antigenic Complex; Hyperlipoproteinemias; Lipoproteins, LDL; Lipoproteins, VLDL; Membrane Glycoproteins; Mice; Mice, Knockout; Mice, Transgenic; Receptors, LDL	1996
The apolipoprotein E2 (Arg145Cys) mutation causes autosomal dominant type III hyperlipoproteinemia with incomplete penetrance. Arteriosclerosis, thrombosis, and vascular biology, 1997, Volume: 17, Issue:5 Topics: Adolescent; Adult; Apolipoprotein E2; Apolipoproteins E; Arginine; Cholesterol, HDL; Cysteine; Female; Heterozygote; Homozygote; Humans; Hyperlipoproteinemias; Male; Middle Aged; Pedigree; Point Mutation; Polymorphism, Restriction Fragment Length; Restriction Mapping; Sequence Analysis, DNA; Triglycerides	1997

Article

Year

In the absence of endogenous mouse apolipoprotein E, apolipoprotein E*2(Arg-158 --> Cys) transgenic mice develop more severe hyperlipoproteinemia than apolipoprotein E*3-Leiden transgenic mice.

The Journal of biological chemistry, 1996, Nov-29, Volume: 271, Issue:48

Topics: Animals; Apolipoproteins E; Arginine; Cells, Cultured; Cysteine; Genes, Dominant; Heymann Nephritis Antigenic Complex; Hyperlipoproteinemias; Lipoproteins, LDL; Lipoproteins, VLDL; Membrane Glycoproteins; Mice; Mice, Knockout; Mice, Transgenic; Receptors, LDL

1996

The apolipoprotein E2 (Arg145Cys) mutation causes autosomal dominant type III hyperlipoproteinemia with incomplete penetrance.

Arteriosclerosis, thrombosis, and vascular biology, 1997, Volume: 17, Issue:5

Topics: Adolescent; Adult; Apolipoprotein E2; Apolipoproteins E; Arginine; Cholesterol, HDL; Cysteine; Female; Heterozygote; Homozygote; Humans; Hyperlipoproteinemias; Male; Middle Aged; Pedigree; Point Mutation; Polymorphism, Restriction Fragment Length; Restriction Mapping; Sequence Analysis, DNA; Triglycerides

1997